693 matches
-
patients with metastatic renal cell carcinoma. J Clin Oncol 2004; 22: 454-463. 8. Fyfe G, Fisher RI, Rosenberg SA et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin 2 therapy. J Clin Oncol 1995; 13: 688-696. 9. Escudier B, Eisen T, Stadler WM et al. Sorafenib în advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125-134. 10. Motzer RJ, Rini BI, Bukowski RM et al. Sunitinib în patients with metastatic
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
RJ, Escudier B, Oudard S et al. Everolimus for advanced renal cell carcinoma. Lancet 2008; 372: 449-456. 12. Choueri T, Plantade A, Elson P et al. Efficacy of sunitinib and sorafenib în metastatic papillary and chromophobe renal cell carcinoma. J Clin Oncol 2008; 26: 127-131. 13. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician 2005; 72: 1723-1732. Tumorile germinale testiculare seminomatoase: Recomandările clinice ESMO privind diagnosticul, tratamentul și urmărirea H.-J. Schmoll*1), K. Jordan
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
clinică oncologică de către experți și conferințele de consens. Bibliografie 1. Stephenson AJ, Bosl GJ, Motzer RJ, et al. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol 2007; 25:5597-5602. 2. Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Clin Oncol 2007; 25:5597-5602. 2. Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998; 16:702-706. 3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594-603. 4. Schmoll HJ, Souchon R, Krege S, et
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998; 16:702-706. 3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594-603. 4. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15:1377-1399. 5
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
germ cell tumor surveillance. Crit Rev Oncol Hematol 2007; 64:182-197. 9. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992; 10:1762-1768. 10. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy în highrisk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14:1106-1113. 11. de
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Council Testicular Tumors Working Party. J Clin Oncol 1992; 10:1762-1768. 10. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy în highrisk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14:1106-1113. 11. de Wit R, Roberts JT, Wilkinson PM, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule în good-prognosis germ cell cancer: a randomized
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule în good-prognosis germ cell cancer: a randomized study of the European Organizațion for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol (2001) 19:1629-1640. 12. Nichols CR, Catalano PJ, Crawford ED, et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide în treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
PJ, Crawford ED, et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide în treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol (1998) 16:1287-1293. 13. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of two or five computed tomography scans în the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Randomized trial of two or five computed tomography scans în the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-The Național Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol (2007) 25:1310-1315. 14. de Wit R, Fizazi K. Controversies în the management of clinical stage I testis cancer. J Clin Oncol (2006) 24:5482-5492. 15. Huddart R, Kataja V. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
the testis: Medical Research Council Trial TE08, ISRCTN56475197-The Național Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol (2007) 25:1310-1315. 14. de Wit R, Fizazi K. Controversies în the management of clinical stage I testis cancer. J Clin Oncol (2006) 24:5482-5492. 15. Huddart R, Kataja V. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol (2008) 19(Suppl 2):ii52-ii54. 16. Pico JL, Rosti G, Kramar A, et al. A randomised
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
practicii clinice de către experți și conferințele de consens. Bibliografie 1. Stephenson AJ, Bosl GJ, Motzer RJ, et al. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol 2007; 25:5597-5602. 2. Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Clin Oncol 2007; 25:5597-5602. 2. Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998; 16:702-706. 3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594-603. 4. Schmoll HJ, Souchon R, Krege S, et
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
etoposide, and cisplatin în favorable-prognosis germ-cell tumors: the Indian University experience. J Clin Oncol 1998; 16:702-706. 3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15:594-603. 4. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15:1377-1399. 5
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
germ cell tumor surveillance. Crit Rev Oncol Hematol 2007; 64:182-197 9. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol (1992) 10:1762-1768. 10. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy în highrisk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14:1106-1113. 11. de
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Council Testicular Tumors Working Party. J Clin Oncol (1992) 10:1762-1768. 10. Cullen MH, Stenning SP, Parkinson MC, et al. Short-course adjuvant chemotherapy în highrisk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14:1106-1113. 11. de Wit R, Roberts JT, Wilkinson PM, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule în good-prognosis germ cell cancer: a randomized
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule în good-prognosis germ cell cancer: a randomized study of the European Organizațion for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001; 19:1629-1640. 12. Nichols CR, Catalano PJ, Crawford ED, et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide în treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
PJ, Crawford ED, et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide în treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol (1998) 16:1287-1293. 13. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of two or five computed tomography scans în the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
Randomized trial of two or five computed tomography scans în the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-The Național Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 2007; 25:1310-1315. 14. de Wit R, Fizazi K. Controversies în the management of clinical stage I testis cancer. J Clin Oncol 2006; 24:5482-5492. 15. Huddart R, Kataja V. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
the testis: Medical Research Council Trial TE08, ISRCTN56475197-The Național Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 2007; 25:1310-1315. 14. de Wit R, Fizazi K. Controversies în the management of clinical stage I testis cancer. J Clin Oncol 2006; 24:5482-5492. 15. Huddart R, Kataja V. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19(Suppl 2) :ii52-ii54. 16. Pico JL, Rosti G, Kramar A, et al. A randomised
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
and prednisone or reduced-intensity autologous stem cell transplantation în elderly patients with multiple myeloma (IFM 99-06): a randomized trial. Lancet 2007; 370: 1209-1218. 10. Greipp PR, San Miguel J, Durie BG et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420. 11. Harousseau JL. Role of stem cell transplantation. Hematol Oncol Clin N Am 2007; 21: 1157-1174. 12. Mead GP, Carr-Smith HD, Drayson MT et al. Serum free light chains for monitoring multiple myeloma. Br J Haematol
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
99-06): a randomized trial. Lancet 2007; 370: 1209-1218. 10. Greipp PR, San Miguel J, Durie BG et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420. 11. Harousseau JL. Role of stem cell transplantation. Hematol Oncol Clin N Am 2007; 21: 1157-1174. 12. Mead GP, Carr-Smith HD, Drayson MT et al. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004; 126: 348-354. 13. Palumbo A, Bringhen S, Caravita T et al. Oral melphalan and
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
pentru practica clinică de către autorii experți și membrii consiliului director al ESMO. Bibliografie 1. Cheson BD, Cassileth PA, Head DR et al. Report on the Național Cancer Institutesponsored workshop on definitions of diagnosis and response în acute myeloid leukemia. J Clin Oncol 1990; 8: 813-819. 2. Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukaemia. Mayo Clin Proc 2006; 81: 247-260. 3. Estey E, Do" hner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907. 4. Appelbaum FR, Pearce SF. Hematopoietic
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
PA, Head DR et al. Report on the Național Cancer Institutesponsored workshop on definitions of diagnosis and response în acute myeloid leukemia. J Clin Oncol 1990; 8: 813-819. 2. Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukaemia. Mayo Clin Proc 2006; 81: 247-260. 3. Estey E, Do" hner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907. 4. Appelbaum FR, Pearce SF. Hematopoietic cell transplantation în first complete remission versus early relapse. Best Pract Res Clin Haematol 2006; 19: 333-339
EUR-Lex () [Corola-website/Law/227406_a_228735]
-
acute myeloid leukaemia. Mayo Clin Proc 2006; 81: 247-260. 3. Estey E, Do" hner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907. 4. Appelbaum FR, Pearce SF. Hematopoietic cell transplantation în first complete remission versus early relapse. Best Pract Res Clin Haematol 2006; 19: 333-339. 5. Stone RM, O'Donnell MR, Sekeres MA. Acute myeloid leukemia. Hematology 2004: 98-117. 6. Smith M, Barnett M, Bassan R et al. Acute myeloid leukemia. Crit Rev Oncol Hematol 2004; 50: 197-222. LEUCEMIA LIMFATICĂ CRONICĂ
EUR-Lex () [Corola-website/Law/227406_a_228735]